Zepbound functions by mimicking two gut hormones—GLP-1 and GIP—to regulate appetite and food intake. This dual-action approach enhances feelings of fullness and reduces hunger, leading to decreased calorie consumption and weight loss.

Clinical studies have shown that individuals using Zepbound can achieve up to a 22.9% reduction in body weight over approximately 3.5 years, with average weight loss ranging between 15% and 20% depending on individual factors.

Most clients begin to notice changes in appetite and weight within 4 to 12 weeks of starting Zepbound. However, results can vary based on diet, physical activity, and individual metabolism.

Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, fatigue, and reactions at the injection site. These side effects are typically mild and diminish over time.

While both medications aid in weight loss, semaglutide (found in Wegovy) targets only the GLP-1 receptor, whereas tirzepatide (found in Zepbound) targets both GLP-1 and GIP receptors. This dual targeting may contribute to greater weight loss efficacy with tirzepatide.

The cost of Zepbound can vary depending on factors like your dosage, pharmacy, and whether you have insurance coverage. At Refine Laser & Skin Care, we’ll help you navigate any available savings programs or insurance benefits to make your treatment as affordable as possible. During your consultation, we’ll provide transparent pricing details and discuss payment options tailored to your needs.

Coverage varies by insurance provider. Some commercial plans cover Zepbound, especially with prior authorization. However, Medicare currently does not cover weight loss medications like Zepbound.